Isaksson K - Search Results

1

Interplay between Caveolin-1 and body and tumor size affects clinical outcomes in breast cancer.

Godina C, Indira Chandran V, Barbachowska M, Tryggvadottir H, Nodin B, Visse E, Borgquist S, Jirström K, Isaksson K, Bosch A, Belting M, Jernström H. Godina C, et al. Among authors: isaksson k. Transl Oncol. 2022 Aug;22:101464. doi: 10.1016/j.tranon.2022.101464. Epub 2022 Jun 1. Transl Oncol. 2022. PMID: 35660849 Free PMC article.

2

Increasing preoperative body size in breast cancer patients between 2002 and 2016: implications for prognosis.

Wisse A, Tryggvadottir H, Simonsson M, Isaksson K, Rose C, Ingvar C, Jernström H. Wisse A, et al. Among authors: isaksson k. Cancer Causes Control. 2018 Jul;29(7):643-656. doi: 10.1007/s10552-018-1042-z. Epub 2018 May 26. Cancer Causes Control. 2018. PMID: 29804217 Free PMC article.

3

The impact of body size changes on recurrence risk depends on age and estrogen receptor status in primary breast cancer.

Tryggvadottir H, Ygland Rödström M, Markkula A, Kenéz X, Isaksson K, Borgquist S, Jernström H. Tryggvadottir H, et al. Among authors: isaksson k. Cancer Causes Control. 2019 Nov;30(11):1157-1170. doi: 10.1007/s10552-019-01227-6. Epub 2019 Sep 12. Cancer Causes Control. 2019. PMID: 31515643

4

Hypoxia Attenuates Trastuzumab Uptake and Trastuzumab-Emtansine (T-DM1) Cytotoxicity through Redistribution of Phosphorylated Caveolin-1.

Indira Chandran V, Månsson AS, Barbachowska M, Cerezo-Magaña M, Nodin B, Joshi B, Koppada N, Saad OM, Gluz O, Isaksson K, Borgquist S, Jirström K, Nabi IR, Jernström H, Belting M. Indira Chandran V, et al. Among authors: isaksson k. Mol Cancer Res. 2020 Apr;18(4):644-656. doi: 10.1158/1541-7786.MCR-19-0856. Epub 2020 Jan 3. Mol Cancer Res. 2020. PMID: 31900313

5

Tertiary lymphoid structures improve immunotherapy and survival in melanoma.

Cabrita R, Lauss M, Sanna A, Donia M, Skaarup Larsen M, Mitra S, Johansson I, Phung B, Harbst K, Vallon-Christersson J, van Schoiack A, Lövgren K, Warren S, Jirström K, Olsson H, Pietras K, Ingvar C, Isaksson K, Schadendorf D, Schmidt H, Bastholt L, Carneiro A, Wargo JA, Svane IM, Jönsson G. Cabrita R, et al. Among authors: isaksson k. Nature. 2020 Jan;577(7791):561-565. doi: 10.1038/s41586-019-1914-8. Epub 2020 Jan 15. Nature. 2020. PMID: 31942071

6

Re-evaluation of HER2 status in 606 breast cancers-gene protein assay on tissue microarrays versus routine pathological assessment.

Sandén E, Khazaei S, Tryggvadottir H, Borgquist S, Isaksson K, Jirström K, Jernström H. Sandén E, et al. Among authors: isaksson k. Virchows Arch. 2020 Aug;477(2):317-320. doi: 10.1007/s00428-020-02768-x. Epub 2020 Feb 20. Virchows Arch. 2020. PMID: 32080761 Free PMC article.

7

Prognostic Impact of Menopausal Hormone Therapy in Breast Cancer Differs According to Tumor Characteristics and Treatment.

Godina C, Ottander E, Tryggvadottir H, Borgquist S, Isaksson K, Jernström H. Godina C, et al. Among authors: isaksson k. Front Oncol. 2020 Feb 6;10:80. doi: 10.3389/fonc.2020.00080. eCollection 2020. Front Oncol. 2020. PMID: 32117735 Free PMC article.

8

Author Correction: Tertiary lymphoid structures improve immunotherapy and survival in melanoma.

Cabrita R, Lauss M, Sanna A, Donia M, Skaarup Larsen M, Mitra S, Johansson I, Phung B, Harbst K, Vallon-Christersson J, van Schoiack A, Lövgren K, Warren S, Jirström K, Olsson H, Pietras K, Ingvar C, Isaksson K, Schadendorf D, Schmidt H, Bastholt L, Carneiro A, Wargo JA, Svane IM, Jönsson G. Cabrita R, et al. Among authors: isaksson k. Nature. 2020 Apr;580(7801):E1. doi: 10.1038/s41586-020-2155-6. Nature. 2020. PMID: 32238929

9

Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer-Impact on Prognosis.

Nilsson L, Sandén E, Khazaei S, Tryggvadottir H, Nodin B, Jirström K, Borgquist S, Isaksson K, Jernström H. Nilsson L, et al. Among authors: isaksson k. Front Oncol. 2020 Jul 29;10:1278. doi: 10.3389/fonc.2020.01278. eCollection 2020. Front Oncol. 2020. PMID: 32850390 Free PMC article.

10

CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients.

Kimbung S, Inasu M, Stålhammar T, Nodin B, Elebro K, Tryggvadottir H, Ygland Rödström M, Jirström K, Isaksson K, Jernström H, Borgquist S. Kimbung S, et al. Among authors: isaksson k. Breast Cancer Res. 2020 Nov 11;22(1):123. doi: 10.1186/s13058-020-01347-x. Breast Cancer Res. 2020. PMID: 33176848 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page